Statement on Senate introduction of the MMAPPP Act

This week U.S. Senators Tina Smith (D-Minn.) and Jeff Merkley (D-Ore.) introduced legislation to ensure that any taxpayer-funded vaccine or treatment for coronavirus (COVID-19) proven to be safe and effective will be accessible, affordable, and available to all individuals.

“The time to end Big Pharma’s business-as-usual is now,” said Margarida Jorge, campaign director for Lower Drug Prices Now. “Congress has the power to ensure everyone gets affordable access to the COVID-19 medicines and vaccines we need to stay healthy,

Statement on Moderna’s 100% taxpayer funded vaccine

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on Moderna exposing that its COVID vaccine is 100% taxpayer-funded:

“Moderna just admitted that its covid vaccine is 100% taxpayer-funded, only a week after comfortably stating before Congress that it plans to make a profit on a vaccine the American people have already paid nearly a billion dollars to develop.

Release: HHS Feels Heat on Vaccine Development Conflicts of Interest

Lower Drug Prices Now and Public Citizen File New Complaints to Ensure Vaccine Czar Is Subject to Ethics Rules

WASHINGTON, D.C. – Public Citizen and Lower Drug Prices Now today filed two additional ethics complaints [here and here] regarding COVID-19 vaccine czar Dr. Moncef Slaoui, following an initial complaint to the U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) in May that resulted in no action.

Statement on $2 billion in tax dollars granted to Sanofi and GSK

The Trump Administration’s Operation Warp Speed has just awarded $2.1 billion — a record amount of taxpayer money — to Sanofi and GSK, pharmaceutical companies working to develop a coronavirus vaccine. The head of Operation Warp Speed, Moncef Slaoui, holds $10 million of shares in GSK. Lower Drug Prices Now has filed an ethics complaint for how the Trump Administration has used a loophole to exempt Slaoui from disclosure rules.

Statement on Moderna’s extra $472 million from taxpayers

On Sunday, Reuters reported that Operation Warp Speed candidate Moderna received an additional $472 million in funding from BARDA to develop its potential COVID vaccine. Following the announcement, Moderna saw shares increase 11.3% in premarket trading on Monday. US taxpayers total funding for the experimental vaccine of Moderna is now $955 million.


“This is yet another massive giveaway to a drug corporation that’s never brought a product to market,

Statement on President Trump’s Executive Orders on drug pricing

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on today’s Executive Orders from the Trump Administration:

“These Executive Orders are not about policy, they’re about politics. The only reason for President Trump’s rekindled interest in lowering drug prices is his dwindling poll numbers, and realization that our country’s senior citizens are abandoning him thanks to his bungled handling of the coronavirus crisis.

Statement on Pfizer receiving $2 billion from taxpayers for COVID vaccine

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on news that U.S. will pay $2 billion for Pfizer/BioNTech coronavirus vaccine doses:

“Anyone that believes these drug corporations aren’t profiting from this pandemic isn’t paying attention. Research shows Pfizer is among corporations profiteering from the pandemic. It’s ridiculous for HHS officials to claim that this vaccine will be available at ‘no cost’ while simultaneously handing over $2 billion in our taxpayer dollars to Pfizer,

Statement on drug executive testimony to House Energy & Commerce Committee

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on today’s E&C Oversight Committee Hearing with Covid Vaccine Manufacturers: 

“Drug corporations are masterful at marketing. They recognize the current race for a COVID vaccine as a fantastic opportunity for free PR to redeem some of their tarnished brands. We expect in today’s subcommittee hearing that officials from AstraZeneca,

Background Memo: Will COVID 19 Vaccines & Medicines Serve Profits or People?

Ahead of tomorrow’s House E&C Oversight subcommittee hearing Lower Drug Prices Now produced this memo with background on Operation Warp Speed, and the five drug corporations leading testifing at tomorrow’s hearing: AstraZeneca, Johnson & Johnson, Merck, Moderna, Novavax and Pfizer. As they try to pat themselves on the back for a job well done, despite their collective refusal to guarantee a safe and affordable vaccine for all Americans, and on top of a long history of price-gouging patients to line their pockets,

Statement on Inspector General’s ruling that Vaccine Czar Moncef Slaoui can keep investing in pharma stocks 

Statement from Margarida Jorge on Inspector General’s ruling that Vaccine Czar Moncef Slaoui can keep investing in pharma firms

“The IG’s decision is extremely disappointing. Mr. Slaoui’s position is core to the government’s vaccine development efforts, and he should be just as accountable to the American people as any other government official. This administration has demonstrated a clear disregard for ethics and a willingness to funnel billions of taxpayer dollars to their Pharma corporate cronies without transparency or accountability.

Statement on Senate Democrats seeking $25bn for COVID19 vaccine

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on news that top Senate Democrats are seeking $25B for Covid-19 vaccine development and distribution:

“Senate Democrats are absolutely right: Americans need affordable COVID vaccines and treatments. And we’re glad that they’re pushing to use the government’s purchasing power to negotiate a ‘fair price’ for patients.

Statement on Operation Warp Speed giving $1.6 billion to Novavax

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on Novavax Receiving $1.6 Billion Via Trump Administration’s Operation Warp Speed:


“Operation Warp Speed continues gambling away billions in taxpayer dollars. The Trump Administration, which is filled with former Pharma execs and lobbyists, just handed over another $1.6 billion to Novavax, a drug corporation that’s never successfully brought a product to market.

Statement on Moderna executives selling stock since pursuing COVID vaccine

Today, the Washington Post reported that top Moderna executives have sold more than $200 million worth of stock since they announced they were pursuing a COVID vaccine in January.

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now:

“This news serves as a reminder that as the White House continues to hand over billions in taxpayer dollars for a coronavirus vaccine without a guarantee of affordability,

Statement on Gilead charging $3,120 for COVID treatment Remdesivir

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now:

“It’s become clear that the only way we’re going to get COVID under control is through a safe, affordable and accessible vaccine. Yet, despite massive taxpayer investments into the development of remdesivir, and guarantees by the company that it will make the drug affordable, Gilead has decided to once again gouge patients.

“Gilead and other Big Pharma corporations have a pattern of donating medicines or promising affordability for positive PR,

Margarida Jorge, national campaign director for Lower Drug Prices Now, applauded the new bills:

Monday, June 22, 2020

“Congress must block Big Pharma’s monopoly control to set prices for medicines developed with taxpayer dollars, especially during a pandemic that’s taken the lives of over 120,000 Americans to date. The time to end Big Pharma business as usual and pass long overdue reforms that increase transparency, accountability and affordability for patients is now. Without an affordable vaccine and treatments, there’s no way to beat COVID 19. Unless Congress intervenes,

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the Trump administration’s pledge to make future covid-19 vaccine free for “vulnerable” Americans:

Wednesday, June 17, 2020

“A commitment to affordability that can’t be made on the record is just another hollow promise to the American people. Like so many things with this administration, this pledge is nothing more than empty rhetoric. As long as Big Pharma companies are given monopoly control to set drug prices, we have no reason to believe that they won’t gouge us for vaccines like they’ve done time and time again.

Lower Drug Prices Now Statement: Black Lives Matter

Tuesday, June 16, 2020

Lower Drug Prices Now joins our partners, allies and people all over the world as we grieve and mobilize over the murders of George Floyd, Breonna Taylor, Ahmaud Arberty, and so many more of our sisters, brothers and trans family members who are casualties of racism and white supremacy. We stand with their families and with the many activists, protesters, and leaders who are on the front lines of the fight to end racist policing,

Leading Drug Pricing and Watchdog Organizations Demand Information from Operation Warp Speed Finalists on COVID Vaccine Pricing

Thursday, June 11, 2020

Groups FOIA HHS seeking information on drug pricing and affordability from agreements with AstraZeneca, Merck and Pfizer 

Washington, D.C. – Today, Lower Drug Prices Now joined nonpartisan ethics watchdog groups American Oversight and Accountable.US in filing Freedom of Information Act (FOIA) requests with the U.S. Department of Health and Human Services (HHS) for information on the pricing,

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the news that 26 Big Pharma companies were sued for price fixing by Attorneys General in 46 states:

Wednesday, June 10, 2020

“At the same time we’re handing billions in taxpayer dollars over to Big Pharma companies for COVID treatments and vaccines, no strings attached, they’re continuing with the same business-as-usual approach of gouging patients. How many times do the same companies have to prove that they can’t be trusted before we lawmakers take action to end Pharma companies’ monopoly control to charge patients any price they want? As we speak,

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on Dr. Anothony Fauci’s comments about not wanting to set price limits for COVID vaccines

Wednesday, June 10, 2020

“For decades, these drug corporations have held the healthcare of billions of people hostage, lining their pockets to become the most profitable industry in the nation,” said Margarida Jorge, national campaign director for Lower Drug Prices Now. “Apparently Dr. Fauci, a senior public health official responsible for our nation’s COVID response, believes that’s okay. Big Pharma should not be the ones deciding the cost of a vaccine,

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the news that AstraZeneca approached Gilead about a potential merger:

Monday, June 8, 2020

“Mergers and consolidation in the pharmaceutical industry is bad news for patients, and could prove even more harmful as demand for affordable COVID treatments and vaccines is bound to increase. Drug corporations already have monopoly control to charge patients inflated prices for prescription drugs in the past few years. Corporations like AstraZeneca and Gilead have historically used their monopoly power to price-gouge patents for necessary medicines, charging sometimes tens of thousands of dollars for a single treatment. 

Vaccine Czar Should Be Subject to Conflict of Interest Code, Groups Say in Ethics Complaint

Co-Leader of the Administration’s Critical Vaccine Program Appears to Have Extensive Web of Conflicting Financial Interests

Thursday, May 28, 2020

WASHINGTON, D.C. – President Donald Trump’s vaccine czar – who has extensive ties to the pharmaceutical industry – should be subject to conflict of interest and disclosure rules, Public Citizen and Lower Drug Prices Now said in a complaint filed today.

In the complaint, filed with the inspector general of the U.S.

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the news that the Vice President’s Chief of Staff, Marc Short, owns stock in companies receiving taxpayer funding for COVID vaccines:

Thursday, May 28, 2020

“At this point, we have to assume that conflicts of interest are a prerequisite to working in the Trump administration,” said Margarida Jorge, national campaign director for Lower Drug Prices Now. “The Vice President’s Chief of Staff holds stock in the very prescription drug corporations receiving taxpayer funding for coronavirus treatments. As the House’s Select Coronavirus Committee investigates the long list of problems with the Trump administration’s coronavirus response,

STATEMENT: Trump Move to Cap Insulin Prices Nothing More Than a Political Stunt

Wednesday, May 27, 2020

WASHINGTON, D.C. — Yesterday, President Trump announced the White House had struck a deal with drug manufacturers to cap the price of insulin at $35 for diabetic Medicare enrollees. The Trump administration’s move, however, is nothing more than a political stunt designed to place a band-aid on a bullet wound. With more than 40 million people nationwide in need of affordable insulin, this proposal only does so for about 3 million Medicare-participating seniors.

National Advocates & Investors Call Out Merck & Co Ahead of Annual Shareholder Meeting: “This Pandemic Is No Time For Business As Usual”

Lower Drug Prices Now and Oxfam join with Merck Investors Oregon State Treasurer to Confront Merck’s Reliance on High-Risk Schemes

Tuesday, May 26, 2020

WASHINGTON – Today, ahead of Merck & Co’s shareholder meeting, Lower Drug Prices Now joined with Merck shareholders, including Oxfam and the Oregon State Treasurer, to issue statements challenging the drug corporation’s record of price gouging and tax avoidance. Merck’s reliance on short-term schemes, such as using monopoly power to hike drug prices is particularly troubling since Merck is now developing a COVID vaccine with direct support from US taxpayers.

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that the U.S. paid AstraZeneca $1.2 billion for a billion doses of its experimental COVID vaccine:

Thursday, May 21, 2020

“It’s Groundhog Day. Another day, another drug corporation with a history of price gouging gets a massive gift of taxpayer dollars, no strings attached. Every taxpayer should be asking the Trump Administration why we are giving AstraZeneca over $1 billion for drugs that were developed with our tax dollars. Beating COVID depends on ensuring these medicines will be affordable.  But instead, the Trump Administration continues to give drug corporations monopoly control over prices to profiteer off the pandemic. 

Reps. Gwen Moore, Donna Edwards Joined Wisconsin Leaders to Demand Affordable COVID Treatments & Vaccines

Wednesday, May 20, 2020

Washington – Today, the Lower Drug Prices Now coalition hosted a tele-town hall featuring Wisconsin Representative Gwen Moore, former Representative Donna Edwards, Stephanie Bloomingdale, President of the Wisconsin AFL-CIO, and Gary Mitchell, President of the Wisconsin Alliance of Retired Americans to demand affordable COVID drugs and accountability for drug corporations that are profiteering off of the coronavirus pandemic.

The town hall comes as multiple drug corporations with a history of price gouging race to develop treatments and vaccines for COVID-19.

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on news from the World Health Assembly on a Public Good Vaccine:

Wednesday, May 20, 2020

Today’s worldwide pandemic should remind us all that we are linked in an international economy where we may all be impacted by developments in nations thousands of miles away. The United States has had a long legacy of global leadership in many areas, but President Trump’s current posture on coronavirus medicines has so far been disappointing, both at home and abroad.

“While Trump and the White House say ‘the last thing anyone is looking for is profit,’ they refuse to commit,


Tuesday, May 19, 2020

“This White House seems to have an open spigot of taxpayer dollars going to drug corporations that profiteer off of pandemics. They’re gearing up to give the largest award in history to a corporate executive who quintupled the price of naloxone in the middle of the opioid epidemic. Yet again, the administration is handing over taxpayer dollars away to a drug corporation with no strings attached and no guarantee that we’ll get affordable access to the medicines developed with our money.

Grassroots Leaders from Maine to California Call on State Attorneys General to Investigate Jaguar Health’s Attempts to Profiteer off the Coronavirus Pandemic

The letters, sent by 33 organizations across 14 states, call for prosecutorial accountability against the drug maker 

Tuesday, May 19, 2020

WASHINGTON – Today, organizations representing 14 states in every region of the U.S. sent letters to their respective Attorneys General requesting that they investigate Jaguar Health’s recent attempts to profiteer off the coronavirus pandemic by tripling the price of the drug Mytesi. Grassroots leaders from across the progressive landscape joined together in a unified response to the actions of Jaguar Health: Big Pharma’s business as usual model must end with COVID.

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that former GlaxoSmithKline executive Moncef Slaoui was named to head the White House’s “Operation Warp Speed”:

Thursday, May 14, 2020

“It should surprise absolutely no one that this White House has put a senior pharma executive in charge of coordinating COVID vaccines and treatments. This is deeply concerning. Once again, the Trump administration has put the fox in charge of the hen house.

“We can’t beat COVID unless we address the public health crisis that has shuttered our economy and already killed over 80,000 people. We need officials and lawmakers who will stand up to drug corporations and ensure that treatments and vaccines for COVID are affordable and accessible to everyone.

Statement by Margarida Jorge on the release of the new COVID relief bill – the HEROES Act

Tuesday, May 12, 2020

“This package focuses on the most immediate relief and recovery needs. We hope President Trump and Senate Leader McConnell will follow Speaker Pelosi’s lead and take swift action to help millions who desperately need it. But we also believe that Congress must take action to stop drug corporations from profiteering off the current pandemic as they have many times in the past on everything from diabetes to HIV/AIDS. Lower Drug Prices Now is working with lawmakers at every level to guarantee that COVID medicines and vaccines will be affordable at low or no cost for everyone.

American Oversight and Lower Drug Prices Now Request Information on COVID-19 Vaccine Pricing 

Wednesday, May 6, 2020 

Washington, DC — Nonpartisan ethics watchdog American Oversight and the Lower Drug Prices Now coalition today filed four Freedom of Information Act (FOIA) requests with the Department of Health and Human Services (HHS) for information on the development of coronavirus vaccines and the agency’s plans for making vaccines available to the public.

The requests ask for the release of written agreements and communications between HHS officials and pharmaceutical companies Johnson &

Attorney General Keith Ellison, Advocates Call On Congress To Take Immediate Action To Make COVID Treatments Affordable To All

Minnesota’s Attorney General, T1International, and national reform leaders join Lower Drug Prices Now to demand No Pandemic Profiteering from Gilead and other drug corporations

Tuesday, May 5, 2020

WASHINGTON — Today, the Lower Drug Prices Now coalition co-hosted a press call following Eli Lilly’s shareholder meeting and in advance of Gilead’s to demand that COVID treatments developed with taxpayer dollars be affordable and accessible to all. 

A recording of the call is available HERE.

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that early trials of Gilead’s Remdesivir have shown positive results

“This is great news. But based on Gilead’s record, we’re deeply concerned that they’ll use their monopoly control to price-gouge patients and make this potentially life-saving treatment unaffordable and inaccessible. Remdesivir was developed using tens of millions of taxpayer dollars, and should be made available at no additional cost. Congress and the Trump administration must require that COVID vaccines and treatments be affordable for all, before it’s too late.”

Background: Gilead has a history of gouging patients.

Seniors, National Leaders Hold Town Hall to Demand Affordable COVID Drugs

Lower Drug Prices Now joined by Congresswoman Debbie Dingell, heads of American Federation of Teachers and Alliance for Retired Americans, and Jon ‘Bowzer’ Bauman to demand No Pandemic Profiteering

Wednesday, April 29, 2020

Washington – Today, the Lower Drug Prices Now coalition co-hosted a telephone town hall to demand access to affordable COVID drugs for seniors and call on Big Pharma not to profiteer off of the coronavirus pandemic.

New Jersey Leaders, Rev. Dr. William Barber II Join Johnson & Johnson Accountability Town Hall to say No to Pandemic Profiteering

Thursday, April 23, 2020

New Jersey — Today, Lower Drug Prices Now coalition partners Health Care Voter, New Jersey Citizen Action, and New Jersey Organizing Project joined together to tell Johnson & Johnson not to profiteer off of the coronavirus pandemic.

The town hall featured Rev. Dr. William Barber II, Illinois State Treasurer Michael Frerichs, policy advisor for Doctors Without Borders Sharonann Lynch, parent advocate Eileen Palazza, secretary-treasurer of Health Professionals and Allied Employees Alexis Rean-Walker,

U.S. Sen. Tom Harkin and Lower Drug Prices Now hold Tele-Town Hall Demanding No Pandemic Profiteering from Drug Corporations

Tuesday, April 21, 2020 

Leaders Urge Congress To Take Action In Next Relief Bill To Ensure Drug Companies Can’t Exploit This Crisis  

Former Senator Tom Harkin joined Lower Drug Prices Now, local groups and Iowans directly impacted by COVID-19, for a tele-town hall Tuesday at 6:00pm CT to urge Congress to take action to prevent pandemic profiteering by drug companies charged with developing COVID treatments and vaccines.

You can listen to a recording of the call here.

Congressmen Garcia & Horsford join Lower Drug Prices Now & Frontline Workers Tele-Town Hall Demanding No Pandemic Profiteering from Drug Corporations 

Wednesday, April 22, 2020 


Leaders Urge Congress To Take Action In Next Relief Bill To Ensure All Workers Get Low Cost COVID Medicines

Congressmen Chuy Garcia and Steven Horsford joined Lower Drug Prices Now and frontline workers for a tele-town hall urging Congress to guarantee affordable medicines and vaccines for workers by preventing pandemic profiteering by drug corporations that received taxpayer funds for developing COVID treatments.

Essential frontline workers in hospitals,

Margarida Jorge, national campaign director for Lower Drug Prices Now, statement on news that the Trump re-election effort received a $50,000 campaign contribution from a maker of hydroxychloroquine in January, before the Trump Administration started pushing the untested drug:

“What a surprise. It appears that Donald Trump’s obsession with pushing an untested, and potentially deadly drug, has more to do with his political health than the country’s health. This is exactly how the system works. Big Pharma uses campaign contributions and their armies of lobbyists to buy influence in Washington to advance their agenda and put their profits over our health. It is shameful and scandalous. And in this case, it may be deadly.

This morning Johnson & Johnson issued a statement reiterating their intent to develop a coronavirus vaccine “on a not-for-profit basis.”

Below is a statement from Margarida Jorge, national campaign director for Lower Drug Prices Now:

“Johnson & Johnson’s promise to provide a future coronavirus vaccine on a ‘not-for-profit basis’ rings hollow. J&J has a record of promising not-for-profit prices on life-saving drugs, and then gouging patients for the same medicines later on. That’s why we know we can’t trust Johnson & Johnson not to profiteer on this one.

“We shouldn’t have to depend on goodwill or promises from drug corporations to get access to affordable treatments and vaccines for COVID-19.

Letter to Presidential Candidates

Lower Drug Prices Now shared recommendations with the Presidential candidates on how to respond to the COVID-19 pandemic and ensure affordable treatments and vaccines for all.

New reporting from the NY Times and Sludge revealed that Big Pharma and the Trump administration are working together to profit off of the coronavirus crisis.

The following is a statement from Margarida Jorge, national campaign director for Lower Drug Prices Now:

“The explosive report in the New York Times showing that President Trump has financial ties to the company making a version of the experimental drug he is pushing raises serious ethical, moral and legal questions that need to be immediately investigated by Congress. Is Trump personally profiting from this crisis? Is he helping his buddies in the pharmaceutical industry profiteer from the pandemic?

Statement: Senate Passes 2 Trillion Coronavirus Relief Bill, But Big Pharma’s Profiteering Remains Unchecked

WASHINGTON (March 26, 2020) – The United States Senate just passed a $2 trillion stimulus bill in response to the coronavirus crisis in the United States. The legislation includes provisions to support hospitals, small businesses and distressed companies caught in the public health and economic fallout from the pandemic.

The following is a statement from Margarida Jorge, national campaign director for Lower Drug Prices Now:

“This package is a step towards helping Americans stay healthy and get back on their feet in the midst of the coronavirus crisis.

Trump Administration gives Gilead greenlight to profiteer on promising COVID-19 Drug.

Instead, Drug Should Come With Affordability Guardrails

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now

Washington, DC (March 24, 2020) — Yesterday the Trump Administration gave the drug corporation Gilead Sciences special monopoly protection on the promising COVID-19 treatment Remdesivir, giving them a green light to price gouge on a desperately needed treatment.

It’s especially outrageous considering the significant public investment taxpayers have made to the research and development of Remdesivir by the United States Army Medical Research Institute of Infectious Diseases and the Centers for Disease Control.

Statement: Drug Corporation Price-Gouged Potential Coronavirus Treatment

WASHINGTON (March 20, 2020) – Since the start of the coronavirus COVID-19 outbreak in the U.S. the Lower Drug Prices Now Coalition has been sounding the alarm about potential Big Pharma price gouging if President Trump and Health and Human Services Secretary Azar fail to enact price control measures that ensure affordability.

Iowa Community Leaders want Guarantee that COVID-19 Vaccine and Treatments will be Accessible and Affordable to Everyone

To listen to the press conference, click: Audio recording (speaking begins at 3:30 mark) of the press conference

(Des Moines, Iowa, March 18, 2020) — We hear a lot from national sources about the continuing needs, concerns and spread of the COVID-19 virus. Today we heard from real Iowans representing Iowa government, small business, healthcare, and senior communities about the effects in Iowa.

Statement: Trump’s Weak Insulin Ploy Does Nothing to Solve the Drug Pricing Crisis

Washington (March 12, 2020) – President Trump announced a new pilot project to cap insulin costs at $35 a month for people with diabetes participating in Medicare Part D. However, the proposed initiative is voluntary for drug makers and insurers and includes no controls on prices or negotiating power.

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now:

“This proposal does nothing to make drug corporations lower prices.

New Drug Pricing Reform Coalition Joins Van Hollen, Schakowsky and Dogget in Calling for Affordable Coronavirus Drugs

WASHINGTON, DC – On Thursday, March 5 at 1pm, the Lower Drug Prices Now (LDPN) coalition, representing millions of Americans angered by Big Pharma’s price-gouging, will join Sen. Chris Van Hollen, and Reps. Jan Schakowsky and Lloyd Doggett in demanding that President Trump and Secretary Azar guarantee that any coronavirus treatment or vaccine developed with taxpayer dollars be affordable for all.

The Lower Drug Prices Now coalition advocates for comprehensive drug pricing reform that prioritizes public health ahead of corporate profit particularly when it comes to medicines funded by taxpayer research.

Statement: President Trump Must Ensure Coronavirus Vaccine is Affordable, Accessible

WASHINGTON (March 3, 2020) – President Trump met with pharmaceutical corporate executives today about finding a vaccine and treatment for the COVID-19 coronavirus, which is approaching 90,000 infections worldwide and has killed six people in the United States.

Despite calls from dozens of lawmakers for the Trump administration to prevent Pharma companies from hiking up the cost of a potential vaccine, Health and Human Services Secretary Alex Azar, a former drug executive himself,

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, in response to Axis Advisors’ data on higher drug prices in 2020.

“Big Pharma rang in the new year with a gift to itself: higher prices and bigger profits on over 200 prescription drugs. Drug corporations are congratulating themselves for keeping most hikes under 10 percent, but let’s be clear: for most hard working Americans, the household budget isn’t growing by 10, or even five percent this year. The upshot? Another year of higher co-pays and out-pocket costs, and another year of having to choose between taking on debt or paying for drugs we need.

Statement from Margarida Jorge on President Trump’s proposal to allow importation of some prescription drugs.

“President Trump’s proposal to import prescription drugs is a poor substitute for real reforms that would guarantee everyone affordable medicine and stop Big Pharma’s price gouging. Instead, Trump’s plan does nothing to fix our fundamentally flawed system. Drug corporations will continue to reap record profits and hike prices without any check on their power. Patients still won’t be able to get hundreds of widely used medicines. Taxpayers will continue to fund research and development, while pharmaceutical corporations will keep using those investment to boost profits at our expense.

High prescription costs are just one way the Big Pharma drug companies rip us off

Margarida Jorge and Frank Clemente

The newly passed House bill allowing Medicare negotiations on drug prices is a first step toward taming Big Pharma and broader corporate abuse.

Last week’s House vote to rein in skyrocketing prescription drug prices was overdue. Now it’s up to the Senate and President Donald Trump to take action.

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the passage of HR3 in the US House of Representatives:

Today’s bipartisan vote to pass the Elijah E. Cummings Lower Drug Prices Now Act is a critical step in helping more patients get the prescription drugs they need to be healthy. For the first time ever, this law would give the government the power to negotiate lower drug prices for millions of seniors and people with disabilities covered by Medicare and people with private insurance coverage. H.R. 3 holds drug corporations accountable for price-gouging patients in order to inflate their profits,

Drug pricing legislation will save lives


If enacted, H.R. 3, the Elijah E. Cummings Lower Drug Prices Now Act, would, for the first time, give the government the power to negotiate lower drug prices for millions of patients enrolled in Medicare, and millions more with private insurance. The stakes are huge: Not only would this save Medicare $500 billion over the next decade, these savings would be used to expand benefits to include dental,

NJ drug manufacturers rake in profits while patients struggle to afford their insulin | Opinion


My mother is one of the 7.4 million Americans who depend on insulin to manage their diabetes.

With insulin prices nearly doubling from 2012 to 2016, my family and millions of others have been forced to cut corners to afford their life-saving medication, all while drug corporations have raked in billions in profits, including two companies based right here in our state.

Commentary: Congress has an opportunity to lower drug costs – and there’s no time to waste


People who take insulin are among those hardest hit by spiraling expenses. A new medication pricing bill would help them.

Americans agree that prescription drug prices are too high. Countless individuals and families across the country are grappling with impossible choices between buying the medication they need to stay healthy and paying the bills. And with no prescription is that truer than insulin.

For diabetics, passage of drug-cost bill is intensely personal | Opinion


Amid the ongoing health care debate in Washington, the House of Representatives will soon consider game-changing legislation that would provide relief to the American public from the high costs of prescription drugs.



In the United States, 30.3 million people live with diabetes. One in four of those people — about 7.5 million people — is forced to ration insulin because of the high price of this life-saving drug. Proverbs 15:27 tells us: “He who is greedy for gain troubles his own house.”

No one should die because they have been priced out of purchasing a lifesaving medicine that costs no more than $6.16 to produce.

Passing House bill would intensify fight against higher drug prices


As people age, they need more prescription drugs to address chronic and age-related health issues at a time when their household income and resources are declining. This issue is especially critical in Florida, which leads the nation in aging seniors, with 20% of the population being 65 or older as of 2017. With no limit on out-of-pocket costs for Medicare drugs, millions of seniors are struggling,

Congress should set fair rules that force drug corporations to negotiate prices


As a pastor, I am deeply invested in the health and well being of my community. Every day, I pray for God to heal those who are sick, and to move our elected leaders to pass policies that end needless suffering.

In the Christian Bible, the Book of James teaches that faith without works is dead. Our religion exhorts us to take meaningful steps to heal the world even as we rely on God’s grace for our ultimate salvation.

The Opioid Crisis Reflects Larger Big Pharma Norms


Prescription opioid overdoses have claimed more than 200,000 lives in the United States over the last decade, ravaging countless towns and cities and emerging as a case study for some of the worst corporate abuse in years.

Drug importation won’t keep Big Pharma in check


This week, the Trump administration announced plans to allow Americans to access lower-cost prescription drugs from Canada at some point in the future. Although importing cheaper drugs is a step in the right direction, it does nothing to solve the crisis that millions of Americans struggling to afford the prescription medicine are facing right now.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles